Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies (Q38097525)

28 August 2017

title

Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies (English)

1 reference

28 August 2017

José Antonio Lorente

2

0 references

Rafael Rosell

series ordinal

3

object named as

Rafael Rosell

1 reference

28 August 2017

Rosa Nadal

1

1 reference

28 August 2017

María Jose Serrano

series ordinal

4

1 reference

28 August 2017

publication date

1 April 2013

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

295-307

1 reference

28 August 2017

cites work

Cancer statistics, 2012

1 reference

Dissecting the metastatic cascade

21 January 2018

1 reference

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial

21 January 2018

1 reference

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

Circulating tumour cells in non-metastatic breast cancer: a prospective study

21 January 2018

1 reference

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer

21 January 2018

1 reference

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

Tumor cell detection in peripheral blood and bone marrow

21 January 2018

1 reference

Circulating tumor cells (CTC) detection: clinical impact and future directions.

21 January 2018

1 reference

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

Biomarkers characterization of circulating tumour cells in breast cancer patients

21 January 2018

1 reference

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

EGFR antagonists in cancer treatment

21 January 2018

1 reference

Targeted therapy of cancer: new roles for pathologists in identifying GISTs and other sarcomas

21 January 2018

1 reference

Detection of mutations in EGFR in circulating lung-cancer cells

21 January 2018

1 reference

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.

21 January 2018

1 reference

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

A perspective on cancer cell metastasis

21 January 2018

1 reference

Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

21 January 2018

1 reference

Epithelial-to-mesenchymal transitions and circulating tumor cells

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer

21 January 2018

1 reference

Circulating cancer cells in division in an early breast cancer patient.

21 January 2018

1 reference

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

21 January 2018

1 reference

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

21 January 2018

1 reference

Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.

21 January 2018

1 reference

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

21 January 2018

1 reference

21 January 2018

Cancer micrometastases

1 reference

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

21 January 2018

1 reference

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

21 January 2018

1 reference

Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

21 January 2018

1 reference

CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes

21 January 2018

1 reference

Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells

21 January 2018

1 reference

Epithelial-mesenchymal transition and cell cooperativity in metastasis

21 January 2018

1 reference

Cadherins and catenins: role in signal transduction and tumor progression

21 January 2018

1 reference

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

21 January 2018

1 reference

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

21 January 2018

1 reference

Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients.

21 January 2018

1 reference

Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal.

21 January 2018

1 reference

Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

21 January 2018

1 reference

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

21 January 2018

1 reference

Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.

21 January 2018

1 reference

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

21 January 2018

1 reference

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer.

21 January 2018

1 reference

Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients

21 January 2018

1 reference

Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling

21 January 2018

1 reference

Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

21 January 2018

1 reference

Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

21 January 2018

1 reference

Breast cancer assessment tools and optimizing adjuvant therapy.

21 January 2018

1 reference

Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact

21 January 2018

1 reference

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

21 January 2018

1 reference

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

21 January 2018

1 reference

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

21 January 2018

1 reference

Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

21 January 2018

1 reference

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

21 January 2018

1 reference

Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients

21 January 2018

1 reference

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

21 January 2018

1 reference

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

21 January 2018

1 reference

Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop

21 January 2018

1 reference

Lapatinib plus capecitabine for HER2-positive advanced breast cancer

21 January 2018

1 reference

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

21 January 2018

1 reference

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.13.7

1 reference

release_l72w4rdy5nbzpjlseejbl6b32e

28 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/l72w4rdy5nbzpjlseejbl6b32e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference